NCT01669434
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
See it on ClinicalTrials.gov ↗275 people
51.6%
48.4%
142 womenmiddle line = equal numbers133 men
- Phase
- PHASE4
- Paid for by
- University of Nebraska
- Finished
- 2016-12-01
- Health conditions
- Hypotension on Induction
- Who could join
- Anyone
- Ages
- 19 Years – 90 Years
- Average age
- mean 63.9 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 87.3% · Black / African American 9.5% · Not reported 1.5% · American Indian / Alaska Native 1.1% · Hispanic / Latina 0.7%
Women left out
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“End-stage renal disease”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Clinical evidence of decompensated heart failure at the time of preoperative evaluation”
- No cancer
Women with current or past cancer were turned away.
“Surgery during which vasopressor use is anticipated (carotid endarterectomy, major abdominal operations, orthopedic oncology)”
Study titles and rules are shown in their original English.